Methods to recruit hard-to-reach groups: Comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia

Journal of Urban Health

Volumn 83, Issue 7 SUPPL., 2006, Pages

  Platt, Lucy ^a   Wall, Martin ^b   Rhodes, Tim ^a   Judd, Ali ^c   Hickman, Matthew ^a,d   Johnston, Lisa G ^e   Renton, Adrian ^b   Bobrova, Natalia ^a   Sarang, Anya ^f  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Central and Eastern European Harm Reduction Network   (Lithuania)

Author keywords

Estonia; HIV; Indigenous field workers; Injecting drug users; Respondent driven sampling; Russia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG USE; ESTONIA; EVALUATION; FEMALE; FIELD WORK; HEALTH CARE DELIVERY; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIGENOUS PEOPLE; INJECTING DRUG USER; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH; RUSSIAN FEDERATION; SAFETY; SAMPLING; THEORETICAL SAMPLE; COST; DISEASE ASSOCIATION; DRUG ABUSE; HEALTH CARE COST; HEALTH SERVICE; HUMAN IMMUNODEFICIENCY VIRUS; INDIGENOUS FIELD WORKER SAMPLING; RESPONDENT DRIVEN SAMPLING; VIRUS TRANSMISSION;

DATA COLLECTION; ESTONIA; FEMALE; HEALTH PERSONNEL; HIV; HIV INFECTIONS; HUMANS; MALE; RUSSIA; SAMPLING STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33845647661     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-006-9101-2     Document Type: Article

References (34)

1. Hamers FF, Downs AM. HIV in central and eastern Europe (review). Lancet. 2003;361(9362): 1035-1044.
2. Rhodes T, Ball A, Stimson G, et al. HIV infection associated with drug injecting in the Newly Independent States, eastern Europe: the social and economic context of epidemics. Addiction. 1999;94:1323-1336.
3. Rhodes T, Sarang A, Bobrik A, Bobkov E, Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy. 2004;15:39-54.
4. AFEW. Officially registered HIV cases in the Russian Federation, 1 January 1987 to 31st December, 2005. Available at: http://www.afew.org/english/ statistics/HIVdata-RF.htm. 2005.
5. UNAIDS/WHO. Guidelines for second generation HIV surveillance: the next decade. Geneva, Switzerland: World Health Organization; 2000, p. 48.
6. Bishop YMM, Fienberg SE, Holland PW. Estimating the Size of a Closed Population. Discrete Multivariate Analysis: Theory and Practice. Cambridge, Massachusetts: MIT; 1975.
7. EMCDDA. Methodological Guidelines to Estimate the Prevalence of Problem Drug Use at Local Level. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2000.
8. UNDCP. GAP Toolkit Module 3: Estimating Prevalence - Indirect Methods for Estimating the Size of the Drug Problem. Vienna: International Centre Austria; 2002.
9. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001;91(1):23-30.
10. Griffiths P, Gossop M, Powis B, Strang J. Researching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction. 1993;88:1617-1626.
11. Kuebler D, Hausser D, Gervasoni J-P. The characteristics of 'new users' of cocaine and heroin unknown to treatment agencies: results from the Swiss Hidden Population Study. Addiction. 2000;95(10):1561-1571.
12. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;46:416-430.
13. Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: multi-city study. Addiction. 2006;101(2):252-266.
14. Goodman LA. Snowball sampling. Ann Math Stat. 1961;32:148-170.
15. Broadhead RS, Heckathorn DD, Grund J-P, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS: preliminary evidence of a peer-driven intervention. J Drug Issues. 1995;23:531-564.
16. Albery I, Strang J, Gossop M, Griffiths P. Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users. Drug Alcohol Depend. 2000;58(1-2):197-204.
17. Des Jarlais DC, Johnston P, Friedmann P, et al. Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China. BMC Public Health. 2005;5(89):1-8.
18. Hunter GM, Stimson G, Judd A, Jones S, Hickman M. Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. Addiction. 2000;95(9):1351-1361.
19. Judd A, Hickman M, Jones S, et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ. 2005;330(7481):24-25.
20. Robson P, Bruce M. A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations? Addiction. 1997;92(12):1729-1736.
21. Stimson GV, Jones S, Sullivan D, Chalmers C. A short questionnaire (IRQ) to assess injecting risk behaviour. Addiction. 1998;93(3):337-347.
22. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174-198.
23. Kilworth PD, Johnsen EC, Bernard HR, Shelly GA, McCarthy C. The reversal small world experiment. Soc Netw. 1978-79;1:159-192.
24. Heckathorn DD. Respondent-driven sampling. II. Deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11-34.
25. Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Method. 2004;34:193-239.
26. Power R. Some methodological and practical implications of employing drug users as indigenous field workers. In: Boulton M, ed. Challenge and Innovation: Methodological Advances in Social Research on HIV/AIDS. London: Taylor and Francis; 1994:97-111.
27. Magnani R, Sabin K, Saidel T, Heckathorn DD. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(Suppl 2):S67-S72.
28. Platt L, Bobrova N, Rhodes T, et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS. 2006 (in press).
29. Rhodes T, Lowndes CM, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS. 2002;16:F25-F31 (May 29).
30. Wall M. Sex and drugs and economic behaviour: results from a survey of drug injectors and sex workers in two Russian cities. 2006 (in press).
31. Rhodes T, Judd A, Mikhailova L, et al. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation. J Acquir Immune Defic Syndr. 2004;35(3):293-300.
32. Konings E. Prostitution and HIV/AIDS in CEE/CIS. Geneva, Switzerland: UNAIDS; 1996.
33. Lakhulamani V. The prostitution situation in a number of cities of Russia, Ukraine and Byelarus. Zhurnal mikrobiologii, epidemiologii, i immunobiologii. 1997;1:102-104 (Jan-Feb).
34. Platt L, Rhodes T, Sarang A, Milhailova L. Ongoing HIV epidemic amongst injecting drug users in Togliatti City, Russian Federation. London School of Hygiene and Tropical Medicine. Unpublished, 2006.